Key considerations for protein targets: Use ideal body weight (IBW) or adjusted body weight for calculations, not current weight in patients with obesity Distribute protein across meals rather than concentrating in one sitting Monitor for signs of inadequate intake: fatigue, weakness, hair loss, or poor wound healing Reassess needs every 36 months as weight changes Consult with a registered dietitian for personalized recommendations GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists exert their appetite-suppressing effects through multiple mechanisms
Code availability The custom code used in this study is freely available on Github ( References Wang, M
The sooner treatment starts, the better the chances for regrowth
On-track check See how your results compare with clinical trials and people on the same medication and dose
How high-protein, nutrient-dense, portion-controlled foods are shaping the future of metabolic health GLP-1 receptor agonists like Ozempic, Wegovy and Mounjaro are reshaping how millions of people eat